: Hypertrophic cardiomyopathy (HCM) is the most prevalent genetically inherited cardiovascular disorder in adults and a significant cause of heart failure and sudden cardiac death. Historically, atrial fibrillation (AF) has been considered a critical aspect in HCM patients as it is considered a marker of disease progression, escalates the frequency of heart failure hospitalizations, increases the risk of thromboembolic events and worsens quality of life and outcome. Increasing evidence suggests that AF is the result of a subtle, long-standing process which starts early in the history of HCM. The process of left atrial dilatation accompanied by morpho/functional remodeling, is the quintessential prerequisite for the onset of AF. This review aims to describe the current understanding of AF pathophysiology in HCM, emphasizing the role of left atrial myopathy in its development. Additionally, we discuss risk factors and management strategies specific to AF in the context of HCM, providing insights into the complexities and challenges of treating such specific patient population.

From atrial fibrillation management to atrial myopathy assessment: the evolving concept of left atrium disease in hypertrophic cardiomyopathy / Fumagalli, Carlo; Zocchi, Chiara; Ciabatti, Michele; Milazzo, Alessandra; Cappelli, Francesco; Fumagalli, Stefano; Pieroni, Maurizio; Olivotto, Iacopo. - In: CANADIAN JOURNAL OF CARDIOLOGY. - ISSN 0828-282X. - STAMPA. - (2024), pp. 1-27. [10.1016/j.cjca.2024.01.026]

From atrial fibrillation management to atrial myopathy assessment: the evolving concept of left atrium disease in hypertrophic cardiomyopathy

Fumagalli, Carlo;Milazzo, Alessandra;Cappelli, Francesco;Fumagalli, Stefano;Olivotto, Iacopo
2024

Abstract

: Hypertrophic cardiomyopathy (HCM) is the most prevalent genetically inherited cardiovascular disorder in adults and a significant cause of heart failure and sudden cardiac death. Historically, atrial fibrillation (AF) has been considered a critical aspect in HCM patients as it is considered a marker of disease progression, escalates the frequency of heart failure hospitalizations, increases the risk of thromboembolic events and worsens quality of life and outcome. Increasing evidence suggests that AF is the result of a subtle, long-standing process which starts early in the history of HCM. The process of left atrial dilatation accompanied by morpho/functional remodeling, is the quintessential prerequisite for the onset of AF. This review aims to describe the current understanding of AF pathophysiology in HCM, emphasizing the role of left atrial myopathy in its development. Additionally, we discuss risk factors and management strategies specific to AF in the context of HCM, providing insights into the complexities and challenges of treating such specific patient population.
2024
1
27
Goal 3: Good health and well-being
Fumagalli, Carlo; Zocchi, Chiara; Ciabatti, Michele; Milazzo, Alessandra; Cappelli, Francesco; Fumagalli, Stefano; Pieroni, Maurizio; Olivotto, Iacopo
File in questo prodotto:
File Dimensione Formato  
fumagalli from atrial fibrillation management to atryal myopathy.pdf

accesso aperto

Tipologia: Pdf editoriale (Version of record)
Licenza: Open Access
Dimensione 4.72 MB
Formato Adobe PDF
4.72 MB Adobe PDF

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/1354513
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 0
  • ???jsp.display-item.citation.isi??? ND
social impact